cyclosporine has been researched along with Cockayne-Touraine Disease in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
De, D; Handa, S; Karim, A; Kaushik, A; Mahajan, R; Saikia, B | 1 |
Boull, CL; Hook, KP; Hylwa, SA; Sajic, D; Tolar, J; Wagner, JE | 1 |
Ito, M; Mizutani, Y; Nakano, H; Sawamura, D; Seishima, M; Takahashi, T | 1 |
Abdel Halim, DM; Abdel Hay, RM; Amin, IM; El-Darouti, MA; Fawzy, MM; Hegazy, RA | 1 |
Anadolu, R; Calikoglu, E | 1 |
del-Río, E | 1 |
Arata, J; Tada, J; Yamasaki, H; Yoshioka, T | 1 |
1 trial(s) available for cyclosporine and Cockayne-Touraine Disease
Article | Year |
---|---|
Mycophenolate mofetil: a novel immunosuppressant in the treatment of dystrophic epidermolysis bullosa, a randomized controlled trial.
Topics: Adolescent; Adult; Child; Child, Preschool; Cyclosporine; Double-Blind Method; Epidermolysis Bullosa Dystrophica; Female; Humans; Immunosuppressive Agents; Infant; Kidney Transplantation; Male; Mycophenolic Acid; Survival Rate; Treatment Outcome; Young Adult | 2013 |
6 other study(ies) available for cyclosporine and Cockayne-Touraine Disease
Article | Year |
---|---|
Successful use of cyclosporine in epidermolysis bullosa pruriginosa.
Topics: Adult; Collagen Type VII; Cyclosporine; Epidermolysis Bullosa; Epidermolysis Bullosa Dystrophica; Humans; Male | 2020 |
Toxic Epidermal Necrolysis in Recessive Dystrophic Epidermolysis Bullosa following Bone Marrow Transplantation.
Topics: Bone Marrow Transplantation; Child, Preschool; Cyclosporine; Epidermolysis Bullosa Dystrophica; Humans; Immunosuppressive Agents; Male; Mesenchymal Stem Cell Transplantation; Stevens-Johnson Syndrome | 2016 |
Dystrophic epidermolysis bullosa pruriginosa successfully treated with immunosuppressants.
Topics: Adult; Aged; Cyclosporine; Epidermolysis Bullosa Dystrophica; Female; Humans; Immunosuppressive Agents; Ribonucleosides | 2016 |
Management of generalized pruritus in dominant dystrophic epidermolysis bullosa using low-dose oral cyclosporin.
Topics: Administration, Oral; Adult; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Epidermolysis Bullosa Dystrophica; Female; Follow-Up Studies; Humans; Pruritus; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2002 |
Prevention of blisters in dystrophic recessive epidermolysis bullosa with cyclosporine.
Topics: Adult; Blister; Cyclosporine; Epidermolysis Bullosa Dystrophica; Female; Humans | 1993 |
Epidermolysis bullosa pruriginosa (McGrath) successfully controlled by oral cyclosporin.
Topics: Cyclosporine; Epidermolysis Bullosa Dystrophica; Humans; Immunosuppressive Agents; Leg Dermatoses; Male; Middle Aged; Prurigo | 1997 |